# Nabd Plus — Phase 0 Root Audit Final Closure Package

**Baseline:** `main @ 22526bedb77a3d8148219036367e4714f401aecc`  
**Audit branch:** `agent/audit-main-contract-inventory`  
**Scope:** Backend, Patient Web, Patient Mobile, Provider and Admin source/contract audit only.  
**Disposition:** `OPEN/PARTIAL — NO-GO`; no remediation, feature activation, deployment, migration or production mutation was performed in Phase 0.

## Executive conclusion

The audit now covers the previously outstanding Mobile Pharmacy, Community, Wallet, Offers, Map, Settings/Support and Therapeutic Programs surfaces, in addition to the earlier Mobile/Web/Provider/Admin evidence. The source proves the existence of many real API primitives, but it does **not** prove a production-ready, end-to-end patient journey for every action. The dominant risks are client-authoritative commerce and financial values, false-success and synthetic fallback states, incomplete owner/stranger/unauth and replay evidence, route/method drift, untyped controller bodies, PHI/attachment exposure, missing data-rights actions, hard-coded legal/security/support claims, and Web↔Mobile capability mismatch.

## Confirmed finding inventory

| Severity | Count | Interpretation |
|---|---:|---|
| P0 | 4 | Release-blocking operational/security/contract risks remain. |
| P1 | 88 | Material correctness, security, truthfulness, lifecycle and parity gaps. |
| P2 | 6 | Important governance/product/parity gaps. |
| **Total** | **98** | `F-001` through `F-098`, each with file/line evidence and acceptance criteria. |

The authoritative register is `confirmed-findings-v1.md`. The latest findings F-087–F-098 consolidate the newly audited Pharmacy checkout/chat/order/prescription surfaces, Wallet, Offers, Map, Support/Community and Settings. They are findings, not completed fixes.

## Coverage status

`phase0-coverage-matrix.md` records all audited domains as `PARTIAL`, `FINDING/PARTIAL`, `READ-ONLY/PARTIAL`, or `VERIFICATION CANDIDATE`; no surface is marked production-complete. The matrix now includes Mobile Therapeutic Programs and the Settings/Support/Data/Language/Wallet/Offers/Map surfaces. `NABD_Main_End_to_End_Traceability_2026-08-24.md` contains twelve journey families and an evidence index.

## Route and contract reconciliation completed

The following fixed-source reconciliations are included:

| Artifact | Confirmed points |
|---|---|
| `backend-route-reconciliation-auth-otp.md` | OTP bridge methods, public guards, httpOnly exchange cookies, coexistence of legacy token/body routes, guest/social/refresh/logout divergence. |
| `backend-route-reconciliation-wallet-pharmacy.md` | Wallet route set and guards, provider/patient ownerType behavior, untyped cards, transfer response limits, pharmacy shortage lookup missing visible CurrentUser binding. |
| `backend-route-reconciliation-support-community-programs.md` | Support/ticket/feedback routes and `body:any`, Community guest fallback under JWT guard, vote method, program enroll/active/complete routes. |
| `backend-route-reconciliation-unified-bookings.md` | Exact root-vs-kind booking routes, POST vs PATCH reschedule distinction, `/unified-bookings/mine`, idempotency decorators and untyped bodies. |
| `backend-route-reconciliation-inventory-2026-08-24.txt` | Raw controller decorator inventory for review. |

## Highest-risk truthfulness findings

Mobile Pharmacy contains local cart/quantity and copied client line values; manual/RX/scan flows use local URI/base64 evidence and zero-priced or client-copied lines; payment and order screens do not yet prove quote/settlement/reconciliation. Wallet contains a hard-coded test-card submission, local default-card state, free-text transfer and incomplete ledger/hosted-payment recovery. Support/Community can synthesize bot/social state or turn failures into empty/success displays. Settings contains empty callbacks for export/portability/deletion, feedback false-success, silent optimistic security/privacy/notification state, and unsupported legal/security/SLA claims.

## Product decisions still blocking scope

`NABD_DECISION_REQUIRED_2026-08-24.md` now contains D-001 through D-026. The new decisions cover wallet PCI/tokenization and transfer beneficiaries, offer redemption semantics, location/default geography/ETA, support model and SLA, data-rights export/deletion and retention, approved legal/security copy, and six-locale synchronization/acceptance. Until decisions have owner, date, contract version and acceptance tests, affected capability remains blocked or inconclusive.

## Required Phase 1 closure gates before build authorization

1. Freeze launch scope: read-only versus enabled commerce; explicitly classify every blocked Mobile mutation.
2. Produce versioned contracts/DTOs for each enabled journey, including schemas, ownership, state machine, error mapping, idempotency and replay behavior.
3. Remove or explicitly block every synthetic fallback, hard-coded test/financial/clinical/legal value and false-success path.
4. Prove owner/stranger/unauth behavior and PHI/attachment/cache isolation for every patient/provider/admin resource.
5. Complete live or approved Sandbox journeys for booking, cancellation, reschedule, call-token, pharmacy cart/checkout/order, insurance, wallet and support; clean up created test data.
6. Complete payment settlement, webhook/outbox, refund/chargeback, expiry and unknown-outcome reconciliation.
7. Complete Web↔Mobile visual, interaction, RTL/six-locale, accessibility, performance and SEO/indexing review under the approved licensing policy.
8. Run Docker/CI/security scans and real startup/rollback checks; verify every closure commit with remote `git ls-remote`.

## Repository verification

The audit branch was repeatedly pushed and verified after each artifact batch. The final Phase 0 package must be considered valid only when the reviewer confirms the branch head with `git ls-remote origin agent/audit-main-contract-inventory` and observes a clean working tree. No merge to `main` is authorized by this package.

## Final verdict

> **NO-GO for a 100% production-readiness claim.**

The project has a substantially stronger, verifiable audit baseline, not a finished production application. Remediation/build work may begin only after reviewer approval of this closure package, explicit decisions D-001–D-026, and a new phase plan that preserves contract-first, truthfulness, ownership, idempotency, PHI and live-verification gates.
